Cabinet approves Rs 9,589 cr FDI in Suven Pharmaceuticals by Cyprus-based firm

[ad_1] News Business Companies Cabinet approves Rs 9,589 cr FDI in Suven Pharmaceuticals by Cyprus-based firm The approval is for acquisition of up to 76.1 per cent shares of Suven…

Suven Pharma stock rises 4% on acquisition by Advent International

[ad_1] Suven Pharma, which was demerged from its parent entity, Suven Life Sciences, in 2020, is one of the leaders in the India pharma CDMO space, with high growth (over…